Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MCLA-158 |
Trade Name | |
Synonyms | MCLA 158|MCLA158|petosemtamab |
Drug Descriptions |
MCLA-158 is a bispecific antibody that targets EGFR and LGR5, potentially resulting in decreased tumor growth (Cancer Res July 1 2017 (77) (13 Supplement) 32). |
DrugClasses | EGFR Antibody 60 |
CAS Registry Number | NA |
NCIT ID | C179196 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MCLA-158 | MCLA-158 | 0 | 2 |
MCLA-158 + Pembrolizumab | MCLA-158 Pembrolizumab | 0 | 1 |